Companies - Galapagos

Price

 
Price
€ 84,82
Change
€ 0,12
Change %
0,14%
Open
€ 84,70
High
€ 85,20
Low
€ 83,34
Volume
323.534

Profile

 
Profile
Galapagos is a service company for the pharmaceutical companies. It is specialized in the discovery of proteins that cause disease. The company is also active in the development of new molecules. While it focuses on arthritis, osteoporosis and osteoarthritis.
Industry
Biotechnology
Description
Companies in the biotechnology industry are performing research and development activities for the purpose of discovering new drugs and diagnostics. The turnover of these companies comes from sales of these products or the sale of licenses of drugs and diagnostic to other companies.

Key figures (2016)

 
The ratios below are calculated using the last known share price and the last known company financials.

Ratios per share

Price to Earnings
71,763
Price to Earnings (3 years)
-372,925
Price to Earnings (5 years)
-430,851
Price to earnings growth
1,982
Price/cashflow
66,608
Price/net cashflow
6,171
Price/book value
5,109
Price to sales
25,565

Ratios for dividend

Dividend yield
-
Pay out
-

Valuation ratios

Market value/PE
5,109
Market value/turnover
25,565
Enterprise value/turnover
19,606

Return ratios

Return on private equity
7,12%
Return on total equity
4,99%
Profit margin
35,62%

Risk ratios

Solvability
0,700
Solvability
3,337
Current ratio
9,704
Debt to Equity
0,428

Value invest ratios

Grahams Number
€ 14,94
Grahams Value
€ -69,88
Grahams Product
366,614
Grahams Product (3 years)
-1.905,145

2016

 

Profit and loss

Net profit (x 1 mln)
€ 54,01
Turnover (x 1 mln)
€ 151,61
Cashflow(x 1 mln)
€ 58,19
Net cashflow(x 1 mln)
€ 628,11

Balance

Private equity (x 1 mln)
€ 758,70
Foreign equity (x 1 mln)
€ 324,64
Current assets (x 1 mln)
€ 1.007,23
Current liabilities (x 1 mln)
€ 103,79
Working capital (x 1 mln)
€ 903,44
Balance total (x 1 mln)
€ 1.083,34

Share

Outstanding shares (x 1 mln)
45,696
Price year-end
€ 60,94
Dividend per share
-
Earnings per share
€ 1,18
Cashflow per share
€ 1,27
Net cashflow per share
€ 13,75
Book value per share
€ 16,60
Stockmarket value (x 1 mln)
€ 2.784,71

History

 
Year
2016
2015
2014
2013
2012
Net profit (x 1 mln)
€ 54,01
€ -118,40
€ 33,21
€ -8,08
€ -5,72
Turnover (x 1 mln)
€ 151,61
€ 60,60
€ 90,02
€ 159,55
€ 152,98
Price year-end
€ 60,94
€ 56,76
€ 15,49
€ 4,85
€ 4,85
Year high
€ 66,19
€ 60,55
€ 17,05
€ 4,85
€ 4,85
Year low
€ 32,50
€ 14,81
€ 4,85
€ 4,85
€ 4,85
Outstanding shares (x 1 mln)
45,696
39,076
30,108
29,794
26,771
Price to Earnings
51,559
-18,733
14,043
-17,884
-22,699
Earnings per share
€ 1,18
€ -3,03
€ 1,10
€ -0,27
€ -0,21
Dividends
-
-
-
-
-
Dividend yield
-
-
-
-
-
Pay out
-
-
-
-
-
Private equity (x 1 mln)
€ 758,70
€ 365,00
€ 206,14
€ 167,14
€ 118,45
PE per share
€ 16,60
€ 9,34
€ 6,85
€ 5,61
€ 4,42
Balance total (x 1 mln)
€ 1.083,34
€ 442,51
€ 270,47
€ 287,37
€ 235,33
Stockmarket value (x 1 mln)
€ 2.784,71
€ 2.217,95
€ 466,37
€ 144,50
€ 129,84

Company analysis

 

Analysis of profit indicators

Average profit per share (5 years)
€ -0,49
Standard deviation average profit
€ 1,58 (-319,77%)
Average annual growth rate
33,68%
Compound annual growth percentage
24,18%
© 2009 Skuzet. All Rights Reserved.